 Geron Co. NASDAQ:GERN Investment analysts at B.Riley Securit issued their Q3 2020 EPS estimates for shares of Geron in a research note issued on Wednesday, October 14th. B.Riley Securit analyst J. Zelin expects that the biopharmaceutical company will earn 0.05 per share for the quarter. B.Riley Securit currently has a Buy rating on the ... 